spacer
home > pmps > winter 2002 > packaging - the future in 3d
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Packaging - The Future in 3D

So - you are a drug company, you have a new chemical entity (NCE) that has taken you eight years to develop. You have run probe studies and the product works (12 months) and a market container study. With all the paperwork to file the drug and get launch approval, the process took a further two years.

Along the way marketing have selected the shape and look they want and identified the launch market. Sales have geared up to sell the product and your affiliates are readying production at five primary and five back-up sites. Already your global procurement is ready to start to reduce the COPS, and the formulation has been passed on for product line extension development.

Packaging technology groups are looking at cost optimisation. The FDA/MCA are watching every step to make sure everything is as it should be. If your drug is a blockbuster then Wall Street and the City, along with your shareholders, have been watching you for the last three years - and anything other than an on-time launch, scale-up and market penetration is a failure for all the scientists, marketers, sales teams and purchasing professionals in the business. Worried?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Nic Hunt, Global Business Director for Rexam Pharma Flexibles and Rexam Pharma Services
Nic Hunt has worked globally in medical, pharmaceutical and personal care packaging for 15 years in research, process development, product development, marketing and business management.

He is currently the Global Business Director for Rexam Pharma Flexibles and Rexam Pharma Services - focusing on developing new barrier systems and packaging solutions for the pharmaceutical industry.

spacer
Nic Hunt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals renews its “Credit Impôt Recherche” (CIR) by the French Ministry of Higher Education and Research

[Noáin, April 22, 2020] 3P Biopharmaceuticals, a European leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has successfully extended its French CIR certificate for another four-year period: 2020-2024.
More info >>

White Papers

Streamlining patient recruitment using EHR data

The field of (bio)pharmaceutical research is booming. Increasingly more innovative therapeutics are being developed with the ability to drastically improve the quality of life of millions of patients around the world. Rigorously testing each of these candidate drugs for their safety and efficacy is an essential part of the development process. As the number of clinical trials steadily increases, the search for patients who present a specific medical profile and are willing to participate intensifies.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement